CCRN icon

Cross Country Healthcare

13.13 USD
-0.67
4.86%
At close Jul 30, 4:00 PM EDT
1 day
-4.86%
5 days
-3.17%
1 month
0.61%
3 months
-3.10%
6 months
-28.02%
Year to date
-27.74%
1 year
-27.22%
5 years
97.15%
10 years
8.33%
 

About: Cross Country Healthcare Inc is a provider of total talent management services, including strategic workforce solutions, contingent staffing, permanent placement and consultative services for healthcare customers. The company operates in two business segments: the nurse and allied staffing segment, which generates a vast majority of revenue, offers temporary and permanent placements of travel and local nurses and allied professionals, and other outsourcing services.: the Physician Staffing segment provides licensed practitioners across a broad array of specialties, as well as certified registered nurse anesthetists (CRNAs), nurse practitioners (NPs), and physician assistants (PAs) on temporary assignments. The company earns majority of its revenue from the United States.

Employees: 10,113

0
Funds holding %
of 7,323 funds
Analysts bullish %

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

0.82% less ownership

Funds ownership: 98.36% [Q4 2024] → 97.53% (-0.82%) [Q1 2025]

9% less funds holding

Funds holding: 174 [Q4 2024] → 159 (-15) [Q1 2025]

17% less capital invested

Capital invested by funds: $577M [Q4 2024] → $477M (-$100M) [Q1 2025]

32% less first-time investments, than exits

New positions opened: 25 | Existing positions closed: 37

33% less repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 64

33% less funds holding in top 10

Funds holding in top 10: 3 [Q4 2024] → 2 (-1) [Q1 2025]

86% less call options, than puts

Call options by funds: $58K | Put options by funds: $410K

Research analyst outlook

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$16.50
26%
upside
Avg. target
$17.56
34%
upside
High target
$18.61
42%
upside

2 analyst ratings

positive
0%
neutral
100%
negative
0%
Barrington Research
Kevin Steinke
42%upside
$18.61
Market Perform
Maintained
17 Jun 2025
UBS
A.J. Rice
26%upside
$16.50
Neutral
Maintained
13 May 2025

Financial journalist opinion

Negative
Zacks Investment Research
1 week ago
Analysts Estimate Cross Country Healthcare (CCRN) to Report a Decline in Earnings: What to Look Out for
Cross Country (CCRN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate Cross Country Healthcare (CCRN) to Report a Decline in Earnings: What to Look Out for
Neutral
Seeking Alpha
1 month ago
Cross Country Healthcare: At This Price, The Pending Acquisition Is Worth Betting On (Rating Upgrade)
I previously rated CCRN a sell, arguing that the FTC could block the merger because of concerns about competition in healthcare markets. The stock price now offers a 45% upside if the Aya merger closes, with the market pricing in only a 22% chance of the deal completing. Management continues to guide toward the deal completing in the second half of 2025.
Cross Country Healthcare: At This Price, The Pending Acquisition Is Worth Betting On (Rating Upgrade)
Positive
Zacks Investment Research
2 months ago
Cross Country Healthcare (CCRN) Q1 Earnings Top Estimates
Cross Country Healthcare (CCRN) came out with quarterly earnings of $0.06 per share, beating the Zacks Consensus Estimate of $0.04 per share. This compares to earnings of $0.19 per share a year ago.
Cross Country Healthcare (CCRN) Q1 Earnings Top Estimates
Neutral
Business Wire
2 months ago
Cross Country Healthcare Announces First Quarter 2025 Financial Results
BOCA RATON, Fla.--(BUSINESS WIRE)--Cross Country Healthcare, Inc. (the Company) (Nasdaq: CCRN) today announced financial results for its first quarter ended March 31, 2025. SELECTED FINANCIAL INFORMATION:       Variance Variance       Q1 2025 vs Q1 2025 vs Dollars are in thousands, except per share amounts Q1 2025 Q1 2024 Q4 2024 Revenue $ 293,408       (23 ) %   (5 ) % Gross profit margin*   20.0   %   (40 ) bps   —   bps Net loss attributable to common stockholders $ (490 )     (118 ) %   87.
Cross Country Healthcare Announces First Quarter 2025 Financial Results
Neutral
Business Wire
3 months ago
Nursing in 2025: No Relief in Sight as Burnout, Stress & Short Staffing Persist
BOCA RATON, Fla.--(BUSINESS WIRE)--Cross Country and FAU release 2025 nursing study, revealing high stress, burnout, and staffing shortages impacting nurses nationwide.
Nursing in 2025: No Relief in Sight as Burnout, Stress & Short Staffing Persist
Positive
Zacks Investment Research
4 months ago
Are Investors Undervaluing Cross Country Healthcare (CCRN) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Are Investors Undervaluing Cross Country Healthcare (CCRN) Right Now?
Positive
Zacks Investment Research
4 months ago
Cross Country (CCRN) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for Cross Country (CCRN) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Cross Country (CCRN) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
Negative
Zacks Investment Research
4 months ago
Cross Country Healthcare (CCRN) Misses Q4 Earnings Estimates
Cross Country Healthcare (CCRN) came out with quarterly earnings of $0.04 per share, missing the Zacks Consensus Estimate of $0.11 per share. This compares to earnings of $0.29 per share a year ago.
Cross Country Healthcare (CCRN) Misses Q4 Earnings Estimates
Neutral
Business Wire
4 months ago
Cross Country Healthcare Announces Fourth Quarter and Full Year 2024 Financial Results
BOCA RATON, Fla.--(BUSINESS WIRE)--Cross Country Healthcare, Inc. (the “Company”) (Nasdaq: CCRN) today announced financial results for its fourth quarter and full year ended December 31, 2024. SELECTED FINANCIAL INFORMATION: Dollars are in thousands, except per share amounts Q4 2024 Variance Q4 2024 vs Q4 2023 Variance Q4 2024 vs Q3 2024 Full Year 2024   Variance 2024 vs 2023 Revenue $ 309,940       (25 ) %   (2 ) % $ 1,344,004       (33 ) % Gross profit margin*   20.0   %   (190 ) bps   (40 ).
Cross Country Healthcare Announces Fourth Quarter and Full Year 2024 Financial Results
Neutral
Zacks Investment Research
4 months ago
5 Broker-Loved Stocks to Keep an Eye on Amid Trade Tensions
Investors should monitor stocks like Cardinal Health, DXC Technology, Cross Country Healthcare, Avnet and Asbury for high returns.
5 Broker-Loved Stocks to Keep an Eye on Amid Trade Tensions
Charts implemented using Lightweight Charts™